Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma

Naoyuki Kawahara, Mayumi Ono, Ken Ichi Taguhi, Masahiro Okamoto, Mitsuo Shimada, Kenji Takenaka, Kenshi Hayashi, Dean F. Mosher, Keizo Sugimachi, Masazumi Tsuneyoshi, Michihiko Kuwano

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)


Cholangiocarcinoma (CCC) is relatively hypovascular, in contrast to hepatocellular carcinoma (HCC), which is often highly vascular. We investigated if the diminished vascularity of CCC is related to altered expression of thrombospondin-1 (TSP-1), an antiangiogenic factor, and/or vascular endothelial growth factor (VEGF), a potent angiogenic factor, comparing the relationships with those of high- and low-vascular HCC. We also investigated the relationship between the mutation of the p53 gene and TSP-1 expression or VEGF expression. Northern blot analysis and immunohistochemical staining were performed on surgically resected human CCC and HCC. The ratios of ISP-1 mRNA level in cancer cells versus adjacent noncancerous cells (T/N ratios) were significantly higher in CCC (n = 11) than in HCC with high vascularity (n = 15). In contrast, T/N ratios of VEGF mRNA level in CCC (n = 11) were comparable with those in HCC with low vascularity (n = 5). In CCC, the cancer cells and fibroblasts were positively stained with anti-TSP-1 antibody. We observed that T/N ratios of VEGF mRNA level, but not those of the TSP-1 mRNA level, were significantly correlated with vascularity in HCC. The relative increase in TSP-1 and the relative decrease in VEGF in tumors compared with normal tissue may underlie the limited angiogenesis of CCC. The p53 gene did not affect the expression of TSP-1 in CCC or VEGF in HCC.

Original languageEnglish
Pages (from-to)1512-1517
Number of pages6
Issue number6
Publication statusPublished - Jan 1 1998

All Science Journal Classification (ASJC) codes

  • Hepatology


Dive into the research topics of 'Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this